Development of an ultra-performance liquid chromatography-Tandem mass spectrometry micromethod for quantification of lamotrigine in human plasma and its use in a bioequivalence trial

Bioanalysis

Volumn 1, Issue 1, 2009, Pages 47-55

  Marceliin Jimeenez, Gabriel ^a   P Angeles Moreno, Alionka Citlali ^a   Mendoza Morales, Luis ^a   Rivera Espinosa, Liliana ^a   Martíínez, Miriam Morales ^a  

^a Servicio de Investigacióón de Farmacologíía Clíínica Hospital General de Mééxico   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; GUANABENZ; LAMOTRIGINE; TRIAZINE DERIVATIVE;

ADULT; ARTICLE; BLOOD; CHEMISTRY; CLINICAL TRIAL; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HALF LIFE TIME; HIGH THROUGHPUT SCREENING; HUMAN; LIQUID CHROMATOGRAPHY; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

ADMINISTRATION, ORAL; ADULT; ANTICONVULSANTS; ANTIHYPERTENSIVE AGENTS; CHROMATOGRAPHY, LIQUID; FEMALE; GUANABENZ; HALF-LIFE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; THERAPEUTIC EQUIVALENCY; TRIAZINES; YOUNG ADULT;

EID: 79953119928     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.09.8     Document Type: Article

References (16)

1. McNamara JO. Pharmacotheraphy of the epilepsies. In: The Pharmacological Basis of Therapeutics (11th Edition). Brunton LL (Ed.). McGraw-Hill Companies, NY, USA 517-518 (2006).
2. Chen C, Casale EJ, Duncan B et al. Pharmacokinetics of lamotrigine in children in the absence of other antiepileptic drugs. Pharmacotherapy 19, 437-441 (1999).
3. Cheng CL, Chou CH, Hu OY. Determination of lamotrigine in small volumes of plasma by high-performance liquid chromatography. J. Chromatogr. B. 817, 199-206 (2005).
4. Incecayir T, Agabeyoglu I, Gucuyener K. Comparison of plasma and saliva concentrations of lamotrigine in healthy volunteers. Arzneimittelforschung 57(8), 517-521 (2007).
5. Saracino MA, Bugamelli F, Conti M et al. Rapid HPLC analysis of the antiepileptic lamotrigine and its metabolites in human plasma. J. Sep. Sci. 30(14), 2249-2255 (2007).
6. Greiner SE, Lower DR, Virji MA et al. Simultaneous determination of lamotrigine, zonisamide, and carbamazepine in human plasma by high-performance liquid chromatography. Biomed. Chromatogr. 21(3), 225-228 (2007).
7. Vermeij TA, Edelbroek PM. Robust isocratic high performance liquid chromatographic method for simultaneous determination of seven antiepileptic drugs including lamotrigine, oxcarbazepine and zonisamide in serum after solid-phase extraction. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 857(1), 40-46 (2007).
8. Saracino MA, Koukopoulos A, Sani G et al. Simultaneous high-performance liquid chromatographic determination of olanzapine and lamotrigine in plasma of bipolar patients. Ther. Drug Monit. 29(6), 773-780 (2007).
9. Bompadre S, Tagliabracci A, Battino M et al. Determination of lamotrigine in whole blood with on line solid phase extraction. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 863(1), 177-180 (2008).
10. Greiner C, Haen E. Development of a simple column-switching high-performance liquid chromatography (HPLC) method for rapid and simultaneous routine serum monitoring of lamotrigine, oxcarbazepine and 10- monohydroxycarbazepine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 854(1-2), 338-344 (2007).
11. Beck O, Öhman I, Nordgren HK. Determination of lamotrigine and its metabolites in human plasma by liquid chromatography-mass spectrometry. Ther. Drug Monit. 28(5), 603-607 (2006).
12. Subramanian M, Birnbaum AK, Remmel RP. High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry. Ther. Drug Monit. 30(3), 347-356 (2008)
13. NOM-177-SSA1-1998. Tests and procedures to demonstrate interchangeability between pharmaceutical formulations. Mexican Health Ministry. Mexico (1998).
14. US Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research and Center for Veterinary Medicine. Guidance for Industry: Bioanalytical Method Validation. Department of Health and Human Services, Food and Drug Administration, Rockville, IN, USA (2001).
15. King R, Bonfglio R, Fernández-Metzler C et al. Mechanistic investigation of ionization suppression in electrospray ionization. J. Am. Mass Spectrom. 11, 942-950 (2000).
16. Annesley TM. Ion suppression in mass spectrometry. Clin. Chem. 49(7), 1041-1044 (2003).